Literature DB >> 3708911

Monoclonal antibodies to human eosinophil plasma membrane antigens enhance the secretion of eosinophil cationic protein.

P C Tai, M Capron, D M Bakes, J Barkans, C J Spry.   

Abstract

This study was done to examine the nature of the membrane constituents involved in the secretion of eosinophil cationic protein (ECP) from human blood eosinophils. Three mouse monoclonal antibodies were used, which showed greater binding to membrane antigens on activated, and light density eosinophils from patients with an eosinophilia, than on nonactivated or normal density eosinophils. All three antibodies (EoN4, EoN5 & EoN6) stimulated normal density human eosinophils to secrete ECP, either alone or in association with sepharose-C3b. The antibodies bound to at least two separate sites on the membrane, which were distinct from the receptors for immunoglobulins, C3b, and eosinophil activating factor. One combination of antibodies increased the amount of ECP which was secreted. The membrane antigen recognized by antibody EoN4 was a glycoprotein, molecular weight 75 kD. These findings showed that ECP secretion may be induced by a wider range of stimuli than has been previously recognized, and that the antigens recognized by these monoclonal antibodies may play an important role in the induction of eosinophil degranulation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3708911      PMCID: PMC1577539     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  36 in total

1.  Surface glycoproteins of human white blood cells. Analysis by surface labeling.

Authors:  L C Andersson; C G Gahmberg
Journal:  Blood       Date:  1978-07       Impact factor: 22.113

2.  Studies on blood eosinophils. I. Patients with a transient eosinophilia.

Authors:  P C Tai; C J Spry
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Damage to schistosomula of Schistosoma mansoni induced directly by eosinophil major basic protein.

Authors:  A E Butterworth; D L Wassom; G J Gleich; D A Loegering; J R David
Journal:  J Immunol       Date:  1979-01       Impact factor: 5.422

Review 5.  Relation between eosinophilia and endomyocardial disease.

Authors:  E G Olsen; C J Spry
Journal:  Prog Cardiovasc Dis       Date:  1985 Jan-Feb       Impact factor: 8.194

6.  Purification and characterization of an antigen involved in neutrophil chemotaxis and degranulation using a monoclonal antibody.

Authors:  T G Cotter; P M Henson
Journal:  Eur J Immunol       Date:  1984-07       Impact factor: 5.532

7.  Monoclonal antibody to human eosinophils recognizing 95 kD surface membrane antigen.

Authors:  K A Foon; S Buescher; E S Kimball; L C Huang; H C Stevenson; G Clarke; T Gregorio; J B Harley
Journal:  Hybridoma       Date:  1983

8.  Histaminase release from human eosinophils.

Authors:  R S Zeiger; H R Colten
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

9.  Plasma membrane antigens on light density and activated human blood eosinophils.

Authors:  P C Tai; D M Bakes; J R Barkans; C J Spry
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

10.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

View more
  7 in total

1.  The effects of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-3 on the secretory capacity of human blood eosinophils.

Authors:  P C Tai; C J Spry
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

2.  Killing of Plasmodium falciparum by eosinophil secretory products.

Authors:  L S Waters; J Taverne; P C Tai; C J Spry; G A Targett; J H Playfair
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

3.  Shape changes, exocytosis, and cytosolic free calcium changes in stimulated human eosinophils.

Authors:  P Kernen; M P Wymann; V von Tscharner; D A Deranleau; P C Tai; C J Spry; C A Dahinden; M Baggiolini
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

4.  Expression of lacto-N-fucopentaose III (CD15)- and sialyl-Lewis X-bearing molecules and their functional properties in eosinophils from patients with the idiopathic hypereosinophilic syndrome.

Authors:  T Satoh; A Knowles; M S Li; L Sun; J A Tooze; G Zabucchi; C J Spry
Journal:  Immunology       Date:  1994-10       Impact factor: 7.397

5.  Eosinophilic gastroenteritis: ultrastructural evidence for a selective release of eosinophil major basic protein.

Authors:  G Torpier; J F Colombel; C Mathieu-Chandelier; M Capron; J P Dessaint; A Cortot; J C Paris; A Capron
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

6.  Immunopathological study of eosinophils in eosinophilic granuloma of bone: evidence for release of three cationic proteins and subsequent uptake in macrophages.

Authors:  A Janin; G Torpier; M Capron; P Courtin; B Gosselin
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

7.  Activation of platelets by eosinophil granule proteins.

Authors:  M S Rohrbach; C L Wheatley; N R Slifman; G J Gleich
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.